𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of function of vascular smooth muscle cells by nitric oxide-dependent and -independent interactions with tumorigenic cells

✍ Scribed by Guillaume Morissette; Eric Petitclerc; François Marceau

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
383 KB
Volume
112
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Little is known about the interaction of tumor cells with host vascular smooth muscle cells. In reconstitution experiments, tumorigenic cell lines (including the rat hepatocarcinoma Morris 7777 and human melanoma M‐21) were cultured for 17 hr in the presence of rat aortic rings, subsequently evaluated in contractility assays (response to phenylephrine and KCl). An agonist‐independent loss of contractility was observed in rings pre‐incubated with either tumorigenic cell lines or their conditioned medium (CM). The depressing effect of Morris cells depends largely on the expression of inducible nitric oxide synthase (iNOS) in smooth muscle cells and was reversed by an inhibitor of this enzyme; iNOS immunoreactivity was verified in some muscular vessels at the periphery of tumors formed by the Morris cell line in rats. The M‐21 melanoma produces cytotoxicity in rat aortic rings (presence of single stranded DNA, cleavage of PARP, in differentiated smooth muscle only), accounting for the irreversible loss of contractility. The cytotoxicity produced by M‐21 CM is not dependent on NO. Gel filtration of CM suggests that both the iNOS‐ and cytotoxicity‐inducing substances from Morris hepatoma cells or M‐21 cells, respectively, are mainly of low molecular weight (1 kDa or less). Other cell lines derived from rat or human tumors produce minimal effects on the rat aorta smooth muscle (H4‐II‐E‐C3) or an irreversible anergy (RBL, MDA‐MB‐231, HEP‐3B, HEP G2). The results emphasize that inhibition of vascular smooth muscle is relevant to tumor biology both by modulation of tumoral hemodynamics and by influencing the state of vessel maturation. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Regulation of endothelin receptors by ni
Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells
✍ Eileen M. Redmond; Paul A. Cahill; Robert Hodges; Shuangmin Zhang; James V. Sitz 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Two important mediators of endothelium-dependent regulation of vascular smooth muscle tone and proliferation are nitric oxide (NO) and endothelin (ET-1). An imbalance between NO and ET-1 may contribute to the alterations in vascular tone characteristic of cardiovascular disease. The objective of thi

Overexpression of protein kinase Cα enha
Overexpression of protein kinase Cα enhances lipopolysaccharide-induced nitric oxide formation in vascular smooth muscle cells
✍ Shaohua Li; Freesia L. Huang; Qingping Feng; Jie Liu; Sharon X. Fan; Thomas M. M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

Our previous studies showed that lipopolysaccharide (LPS)-induced nitric oxide (NO) synthesis in cardiovascular tissues is attenuated by protein kinase C (PKC) inhibitors. In the current study, we identify a specific PKC isotype involved in the LPS signal transduction pathway that leads to NO format

Phenotype modulation in cultures of vasc
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: Association with increased nitric oxide synthase expression and superoxide anion generation
✍ Assunta Pandolfi; Alfredo Grilli; Carlo Cilli; Antonia Patruno; Andrea Giaccari; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

## Abstract Proliferative modification of vascular smooth muscle cell (vSMC) and impaired bioavailability of nitric oxide (NO) have both been proposed among the mechanisms linking diabetes and atherosclerosis. However, diabetes induced modifications in phenotype and nitric oxide synthase(s) (NOS) e

Inhibition of PDGF-stimulated and matrix
Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors
✍ Kouros Motamed; Sarah E. Funk; Hidenori Koyama; Russell Ross; Elaine W. Raines; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

## Abstract Interactions among growth factors, cells, and extracellular matrix regulate proliferation during normal development and in pathologies such as atherosclerosis. SPARC (secreted protein, acidic, and rich in cysteine) is a matrix‐associated glycoprotein that modulates the adhesion and prol

Nitric oxide releasing reagent, S-nitros
Nitric oxide releasing reagent, S-nitroso-N-acetylpenicillamine, enhances the expression of manganese superoxide dismutase mRNA in rat vascular smooth muscle cells
✍ Hiroaki Sano; Makoto Hirai; Hidehiko Saito; Izumi Nakashima; Ken-ichi Isobe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Cultured rat vascular smooth muscle cells (VSMCs) produce nitric oxide (NO) under stimulation by lipopolysaccharide (LPS) and interferon-y (IFN-y). NO synthase (NOS) and manganese superoxide dismutase (Mn-SOD) mRNA expressions are simultaneously induced by these stimulants in rat VSMCs. In VSMCs, S-

Oxidized low-density lipoprotein promote
Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating Osterix expression in an Msx2-dependent manner
✍ Jesse Taylor; Martin Butcher; Melec Zeadin; Amanda Politano; Stephen G. Shaughne 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract We have previously shown that oxidized low‐density lipoproteins (oxLDLs) act synergistically with β‐glycerophosphate to induce the osteogenic differentiation of primary bovine aortic smooth muscle cells (BASMCs). In the present study, we attempt to resolve the mechanism responsible for